Thomas J. Sullivan, president and CEO of Symmetry Medical, said the company’s strong financial results indicated that the challenging market conditions may have abated, according to the news release. The success can also be attributed to success in the company’s orthopedic device business.
The company reported $42.3 million in revenue from instrument sales, a 32 percent increase over 4Q of 2009. The implant revenues increased 6 percent from last year, totaling $26.2 million.
Read the news release about Symmetry Medical’s 4Q results.
Read other coverage about Symmetry Medical:
– Symmetry Medical Reports $91.5M in Total Revenue for 3Q, 5% Increase
– Symmetry Medical Names Jose Fernandez Senior Vice President of New Product Development
